This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Invacare Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Geoff Purtill

İcra Kurulu Başkanı

US$918.3k

Toplam tazminat

CEO maaş yüzdesi	53.0%
CEO görev süresi	less than a year
CEO sahipliği	0.07%
Yönetim ortalama görev süresi	2.8yrs
Yönetim Kurulu ortalama görev süresi	3.1yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Geoff Purtill'un ücretlendirmesi Invacare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Dec 31 2022	US$918k	US$486k	-US$101m

Tazminat ve Piyasa: Geoff 'nin toplam tazminatı ($USD 918.28K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 472.15K ).

Tazminat ve Kazançlar: Geoff şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.

CEO

Geoff Purtill (52 yo)

less than a year

Görev süresi

US$918,284

Tazminat

Mr. Geoffrey P. Purtill, also known as Geoff, serves as President and Chief Executive Officer at Invacare Corporation since November 2022 and serves as its Director since December 09, 2022 and served as it...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Geoffrey Purtill	CEO, President & Director	less than a year	US$918.28k	0.073% € 381.3
Kathleen Leneghan	Senior VP & CFO	5.5yrs	US$777.11k	0.34% € 1.8k
Anthony LaPlaca	Senior VP	14.3yrs	US$561.04k	0.23% € 1.2k
Lois Lee	Director of Treasury & Investor Relations	no data	Veri yok	Veri yok
Cintia Ferreira	Chief Human Resources Officer	less than a year	Veri yok	Veri yok
Joost Beltman	Senior Vice President of Commercial Operations & Central	2.8yrs	US$800.41k	0.053% € 274.9

2.8yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: IV3 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Geoffrey Purtill	CEO, President & Director	less than a year	US$918.28k	0.073% € 381.3
Aron Schwartz	Independent Director	1.2yrs	US$118.63k	Veri yok
Edward Crawford	Independent Director	less than a year	US$31.11k	Veri yok
Michael Merriman	Independent Non-Executive Chairman	9yrs	US$170.95k	Veri yok
Clifford Nastas	Lead Independent Director	8yrs	US$162.46k	0.23% € 1.2k
Steven Rosen	Independent Director	less than a year	US$31.11k	Veri yok
Marc Gibeley	Independent Director	7.5yrs	US$165.67k	0.18% € 960.2
Petra Danielsohn-Weil	Independent Director	5yrs	US$144.92k	0.14% € 719.8

3.1yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IV3 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.1 yıldır).

This company listing is no longer active

Invacare Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Invacare Corporation Appoints Geoffrey P. Purtill as President

Invacare Corporation Announces Executive Changes

Invacare Corporation Announces Board and Committee Appointments

Invacare Corporation, Annual General Meeting, May 19, 2022

Independent Director recently sold €50k worth of stock

Recent updates

Invacare Corporation(OTCPK:IVCR.Q) dropped from S&P TMI Index

NYSE to Suspend Trading Immediately in Invacare Corporation and Commence Delisting Proceedings

Invacare Corporation Filed for Bankruptcy

Invacare Corporation Filed for Bankruptcy

Invacare Corporation Appoints Geoffrey P. Purtill as President

Third quarter 2022 earnings released: US$0.92 loss per share (vs US$0.65 loss in 3Q 2021)

Invacare Corporation to Report Q3, 2022 Results on Nov 07, 2022

Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

Invacare Corporation Announces Executive Changes

Invacare Corporation Announces Board and Committee Appointments

Second quarter 2022 earnings released

Invacare Corporation to Report Q2, 2022 Results on Aug 08, 2022

Invacare Corporation(NYSE:IVC) dropped from Russell 2000 Value Index

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

First quarter 2022 earnings released: US$0.69 loss per share (vs US$0.41 loss in 1Q 2021)

Invacare Corporation Reaffirms Revenue Guidance for the Full Year 2022

Invacare Corporation to Report Q1, 2022 Results on May 09, 2022

Invacare Corporation, Annual General Meeting, May 19, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Invacare Corporation to Report Q4, 2021 Results on Mar 08, 2022

Invacare Corporation Introduces Its Next Generation E-Fix Eco Power Assist Device to Transform the Manual Wheelchair

Invacare Corporation Introduces New, Narrow Version of Invacare® AVIVA® STORM RX™ Rear Wheel Drive Power Wheelchair

Invacare Announces New Features in LiNX® 3 Electronics

Senior VP & GM of EMEA Ralf Ledda has left the company

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.65 loss per share (vs US$0.21 loss in 3Q 2020)

Forecast to breakeven in 2023

Invacare Corporation Provides Sales Guidance for the Third Quarter and Full Year 2021

Independent Director Baiju Shah has left the company

Independent Director recently sold €50k worth of stock

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.48 loss in 2Q 2020)

Invacare Corporation Introduces the Invacare® AVIVA STORM RX, a Next Generation Rear Wheel Drive Power Wheelchair

First quarter 2021 earnings released: US$0.41 loss per share (vs US$0.022 profit in 1Q 2020)

Invacare Corporation Reaffirms Earnings Guidance for the Full Year 2021

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations

Invacare Corporation and Its Subsidiary, Alber Usa, LLC Introduces the Next Generation Alber E-Motion® Power Assist Device

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations

Invacare Corporation to Report Q4, 2020 Results on Feb 10, 2021

New 90-day high: €8.20

New 90-day high: €7.90

New 90-day high: €7.50

Invacare Corporation Launches the AVIVA™ FX – MPS Maxx Multi-Position Power Standing System

Third-quarter earnings released: Revenue beats expectations

Third quarter earnings released

Invacare Corporation to Report Q3, 2020 Results on Oct 29, 2020

Invacare Corporation Introduces New ISA™ Premier Series Stand Assist Lifts Into the U.S. Market

New 90-day high: €6.85

New 90-day low - €5.30

First half earnings released

Invacare Corporation to Report Q2, 2020 Results on Aug 05, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş